NDC11 00173089314
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00173-0893-14 | 00173-0893 |
| 00173-893-14 | 00173-893 |
| 0173-0893-14 | 0173-0893 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trelegy Ellipta | FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | GlaxoSmithKline LLC | b5a81d5a-4648-4c7a-951d-33c014a63c7e | 2023-06-02 | Warnings, Adverse reactions | 0173-0893-14 0173-0893 00173089314 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.